First Ever Topical Gene Therapy Approved For “Butterfly Disease” Children

Topical gene therapy VYJUVEK approved Butterfly Disease Epidermolysis Bullosa Beremagene Geperpavec (B-VEC) EBRP

Read the full post on Forbes - Healthcare

Greg Licholai, MD, Contributor